title: Tumour stimulating effects of recombinant human interleukin-6.
authors.forename: C
authors.initials: C
authors.lastname: Ravoet
authors.forename: J
authors.initials: J
authors.lastname: DeGrève
authors.forename: K
authors.initials: K
authors.lastname: Vandewoude
authors.forename: J
authors.initials: J
authors.lastname: Kerger
authors.forename: J P
authors.initials: JP
authors.lastname: Sculier
authors.forename: P
authors.initials: P
authors.lastname: Lacor
authors.forename: P
authors.initials: P
authors.lastname: Stryckmans
authors.forename: M
authors.initials: M
authors.lastname: Piccart
mesh_terms: D000328:Adult; D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy*; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies
chemical_list: D015850:Interleukin-6